Teva Pharmaceutical Industries Limited (NYSE:TEVA) announces a quarterly dividend of  $0.09

ME Staff
-
0



Teva Pharmaceutical Industries Limited (NYSE:TEVA) to go ex-dividend.
On 8/7/2017 Teva Pharmaceutical Industries Limited ( NYSE:TEVA ) announced that it will be issuing a quarterly dividend in the amount of $0.09 down from Previous Dividend: $0.34 $0.09 making the yield 1.83%.


Teva Pharmaceutical Industries Limited (NYSE:TEVA) Ex- dividend date

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is set to go ex-dividend on 8/25/2017 and will be payable on 9/14/2017


Dividend History for Teva Pharmaceutical Industries Limited (NYSE:TEVA)
The next payable dividend for Teva Pharmaceutical Industries Limited is scheduled for 9/14/2017. There is an annual dividend of $$1.16 with a yield of 6.24% The company’s dividend has increased by 2.10% on a 3 Year Average The payout ration for the trailing 12 months of earnings is -18.95% , 26.13% based on this years estimates and 27.17% based on next years projected estimates.

Recent Dividend History for Teva Pharmaceutical Industries Limited (NYSE:TEVA)

  • On 2/8/2013 Teva Pharmaceutical Industries Limited announced a quarterly dividend of $0.31.
  • On 5/6/2013 Teva Pharmaceutical Industries Limited announced a special dividend of $0.32.
  • On 8/1/2013 Teva Pharmaceutical Industries Limited announced a quarterly dividend of $0.32.
  • On 8/5/2013 Teva Pharmaceutical Industries Limited announced a quarterly dividend of $0.32.
  • On 11/1/2013 Teva Pharmaceutical Industries Limited announced a quarterly dividend of $0.33.



    Recent Analyst Rating for Teva Pharmaceutical Industries Limited (NYSE:TEVA)

    • On 8/7/2017 Barclays PLC, Lower Price Target, to Equal Weight with a price target of $38.00 to $23.00
    • On 8/4/2017 Piper Jaffray Companies, Reiterated Rating, to Hold with a price target of $23.00
    • On 8/3/2017 Cantor Fitzgerald, Set Price Target, to Hold with a price target of $27.00
    • On 8/4/2017 Sanford C. Bernstein, Downgrade, fromOutperform to Market Perform to Outperform
    • On 8/4/2017 Maxim Group, Reiterated Rating, to Hold with a price target of $35.00
    • On 8/4/2017 Cowen and Company, Downgrade, fromOutperform to Market Perform to Outperform with a price target of $30.00



    Recent Trading for Teva Pharmaceutical Industries Limited (NYSE:TEVA)
    Shares of Teva Pharmaceutical Industries Limited closed the previous trading session at 18.59 down -2.01 -9.76% with 85,040,419 shares trading hands.